Followers

November 21, 2023

Lupin receives US FDA approval for pitavastatin tablets

Pitavastatin tablets are indicated as an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: Adults with primary hyperlipidemia; Adults and paediatric patients aged 8 years and older with heterozygous familial hypercholesterolemia (HeFH).


No comments:

Post a Comment